Names | |
---|---|
IUPAC name
[(2R,3R)-1,3,4-Trinitrooxybutan-2-yl] nitrate
| |
Other names
Erythrityl tetranitrate (INN)
| |
Identifiers | |
3D model (JSmol)
|
|
1730082 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.027.940 |
EC Number |
|
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C4H6N4O12 | |
Molar mass | 302.108 g·mol−1 |
Density | 1.7219 (±0.0025) g/cm3 |
Melting point | 61 °C (142 °F; 334 K) |
Boiling point | Decomposes at 160 °C |
0.00302 g/100 mL | |
Hazards | |
GHS labelling: | |
NFPA 704 (fire diamond) | |
Explosive data | |
Shock sensitivity | Medium (2.0 Nm) |
Friction sensitivity | Medium |
Detonation velocity | 8200 m/s |
RE factor | 1.60 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Erythritol tetranitrate (ETN) is an explosive compound chemically similar to PETN,[1] though it is thought to be slightly more sensitive to friction and impact.
Like many nitrate esters, ETN acts as a vasodilator, and was the active ingredient in the original "sustained release" tablets, made under a process patent in the early 1950s, called "nitroglyn".[citation needed] Ingesting ETN or prolonged skin contact can lead to absorption and what is known as a "nitro headache".